key: cord-0936561-a4xlrw1t
authors: Dakay, Katarina; Kaur, Gurmeen; Mayer, Stephan A.; Santarelli, Justin; Gandhi, Chirag; Al-Mufti, Fawaz
title: Cerebral Herniation Secondary to Stroke-associated Hemorrhagic Transformation, Fulminant Cerebral Edema in Setting of COVID-19 Associated ARDS and Active Malignancy
date: 2020-10-10
journal: J Stroke Cerebrovasc Dis
DOI: 10.1016/j.jstrokecerebrovasdis.2020.105397
sha: e48a3ad5b80980d6a118a6a95e9248a23178d789
doc_id: 936561
cord_uid: a4xlrw1t

SARS-CoV-2 infection has been associated with ischemic stroke as well as systemic complications such as acute respiratory failure; cytotoxic edema is a well-known sequelae of acute ischemic stroke and can be worsened by the presence of hypercarbia induced by respiratory failure. We present the case of a very rapid neurologic and radiographic decline of a patient with an acute ischemic stroke who developed rapid fulminant cerebral edema leading to herniation in the setting of hypercarbic respiratory failure attributed to SARS-CoV-2 infection. Given the elevated incidence of cerebrovascular complications in patients with COVID-19, it is imperative for clinicians to be aware of the risk of rapidly progressive cerebral edema in patients who develop COVID-19 associated acute respiratory distress syndrome.

COVID-19 infection due to the novel Coronavirus is associated with systemic hyperinflammatory state and hypercoaguability 1 ; recent reports suggest an association between COVID-19 and ischemic stroke 2 . Cytotoxic edema is associated with ischemic stroke and typically peaks within days 3-5; in cases of large hemispheric infarct, malignant cerebral edema can lead to mass effect and herniation. Many metabolic factors can worsen cerebral edema, such as hyponatremia, hypercapnia, and hyperammonemia, amongst others 3 . Hypercapnia is known to induce vasodilation of the intracranial vessels leading to increased cerebral blood volume and in severe cases, cerebral ede-ma. COVID-19 infection has been shown to induce acute respiratory distress syndrome (ARDS) and acute respiratory failure; in patients with ischemic stroke, this may lead to acutely worsening cerebral edema. We report a case of rapidly progressive cerebral edema and herniation in a patient with COVID-19 associated respiratory failure and ischemic stroke.

A 72 year old woman with breast cancer on chemotherapy and blood loss anemia due to gastrointestinal bleed presented to an outside hospital with sudden onset left sided weakness beginning several hours prior to presentation; NIHSS was 6 for left arm plegia, partial left homonymous hemianopia, and right gaze preference. She had also endorsed dyspnea when supine for the preceding week. She was not given tPA due to thrombocytopenia, and was transferred to our center for consideration of endovascular therapy. On arrival, CT brain showed a posterior division right MCA/parietal stroke and CT angiogram showed no large vessel occlusion, indicating recanalization ( Figure   1A ,B). Perfusion CT showed a matched 22 ml core and perfusion deficit. (Figure 2 ). Given the patient's medical comorbidities, she was transitioned to comfort care.

COVID-19 is known to induce a hyperinflammatory state and hypercoaguable state, which may have precipitated the ischemic stroke in this patient, it is also possible that the patient's systemic malignancy contributed to her hypercoaguability. Cytotoxic cerebral edema is a well-described complication of ischemic stroke, particularly malignant middle cerebral artery infarction, but is typically associated with with larger strokes involving more than half the middle cerebral artery territory. The degree and rapidity of deterioration in clinical exam was out of proportion with what is expected with with a stroke of this size and location. In this case, the patient's abrupt decline during hospitalization was likely multifactorial: thrombocytopenia may have been related to both the chemotherapy as well as the underlying COVID-19 infection and likely contributed to the patient's hemorrhagic transformation and exacerbated the development of cerebral edema. Acute respiratory failure in the face of COVID-19 infection likely led to hypercarbia, and this hypercarbia likely potentiated the rapidity and severity of the cerebral edema. Hypercarbic respiratory failure has previously been associated with the devel-opment of fulminant cerebral edema 4 , although the rapid progression seen in our patient was atypical. Acute respiratory distress syndrome (ARDS) is a well-documented complication of COVID-19 infection, and can lead to a severe and rapid respiratory decline leading to hypercarbia and hence precipitate cerebral vasodilation via perivascular extracellular pH changes 4 . In our case, the patient had additional precipitating factors of thrombocytopenia due to concomitant chemotherapy as well as concomitant hematologic derangements from COVID-19 infection which may have increased the likelihood of hemorrhagic transformation; it is likely that these issues also played a role in the patient's neurologic decline.

Given the elevated incidence of cerebrovascular complications in patients with COVID-19, it is important for clinicians to be aware of the potential for this association and to preemptively monitor for hypoxia and hypercarbia and monitor for signs of rapid deterioration especially in patient at higher risks for hypercoaguable states.

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Young and middle-aged people, barely sick with covid-19, are dying from strokes

Pathogenesis of brain edema and investigation into antiedema drugs

Global cerebral edema from hypercapnic respiratory acidosis and response to hyperosmolar therapy

Figure 1: 1A shows completed right parietal stroke; 1B demonstrates spontaneous recanalization of the parent vessel Figure 2: Worsening mass effect, hemorrhage and edema after the patient's respiratory decline